Dr. Agus weighs in on Johnson & Johnson COVID vaccine, risks of Omicron variant
The FDA says the Johnson and Johnson COVID-19 vaccine should be used as a last resort due to rare but potentially severe blood clots. CBS News medical contributor Dr. David Agus joins Vladimir Duthiers and Anne-Marie Green to discuss on the latest developments.